The efficacy and safety of interval and post-reTURBT intravesical therapy for bladder cancer. Chen D, Li Z, Sui Y, Zeng Y, et al. iScience 2025;28:114152.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen D, Li Z, Sui Y, Zeng Y, et al. The efficacy and safety of interval and post-reTURBT intravesical therapy for bladder cancer. iScience 2025;28:114152.
PMID: 41438067